169 related articles for article (PubMed ID: 31140647)
1. Lessons learned from SMAD4 loss in squamous cell carcinomas.
Hernandez AL; Young CD; Wang JH; Wang XJ
Mol Carcinog; 2019 Sep; 58(9):1648-1655. PubMed ID: 31140647
[TBL] [Abstract][Full Text] [Related]
2. Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.
Hernandez AL; Wang Y; Somerset HL; Keysar SB; Aisner DL; Marshall C; Bowles DW; Karam SD; Raben D; Jimeno A; Varella-Garcia M; Wang XJ
Mol Carcinog; 2019 May; 58(5):666-673. PubMed ID: 30575147
[TBL] [Abstract][Full Text] [Related]
3. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.
Bornstein S; White R; Malkoski S; Oka M; Han G; Cleaver T; Reh D; Andersen P; Gross N; Olson S; Deng C; Lu SL; Wang XJ
J Clin Invest; 2009 Nov; 119(11):3408-19. PubMed ID: 19841536
[TBL] [Abstract][Full Text] [Related]
4. Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse.
Teng Y; Sun AN; Pan XC; Yang G; Yang LL; Wang MR; Yang X
Cancer Res; 2006 Jul; 66(14):6972-81. PubMed ID: 16849541
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
[TBL] [Abstract][Full Text] [Related]
6. Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
Chiou J; Su CY; Jan YH; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2017 Aug; 7(1):9830. PubMed ID: 28852126
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4.
Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y
Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607
[TBL] [Abstract][Full Text] [Related]
8. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
9. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX
Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
11. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
12. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.
Fukuchi M; Masuda N; Miyazaki T; Nakajima M; Osawa H; Kato H; Kuwano H
Cancer; 2002 Aug; 95(4):737-43. PubMed ID: 12209716
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice.
Li W; Qiao W; Chen L; Xu X; Yang X; Li D; Li C; Brodie SG; Meguid MM; Hennighausen L; Deng CX
Development; 2003 Dec; 130(24):6143-53. PubMed ID: 14597578
[TBL] [Abstract][Full Text] [Related]
14. Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors.
Haeger SM; Thompson JJ; Kalra S; Cleaver TG; Merrick D; Wang XJ; Malkoski SP
Oncogene; 2016 Feb; 35(5):577-586. PubMed ID: 25893305
[TBL] [Abstract][Full Text] [Related]
15. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.
Hunt KK; Fleming JB; Abramian A; Zhang L; Evans DB; Chiao PJ
Cancer Res; 1998 Dec; 58(24):5656-61. PubMed ID: 9865717
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma.
Goldie SJ; Chincarini G; Darido C
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060263
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.
Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK
Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and HIV infection in patients with anal squamous-cell carcinoma.
Gervaz P; Efron J; Poza AA; Chun SW; Pham TT; Woodhouse S; Wexner SD; Carethers JM
Dis Colon Rectum; 2001 Oct; 44(10):1503-8. PubMed ID: 11598481
[TBL] [Abstract][Full Text] [Related]
20. Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?
Zhang M; Biswas S; Qin X; Gong W; Deng W; Yu H
Cancer Med; 2016 Aug; 5(8):2048-60. PubMed ID: 27228302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
